Advertisement SGI, NEB sign licensing agreement for Gibson Assembly master mix - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

SGI, NEB sign licensing agreement for Gibson Assembly master mix

Synthetic Genomics (SGI) and New England Biolabs (NEB) have entered into a non-exclusive licensing agreement whereby NEB will commercialize the Gibson Assembly master mix.

The financial details of the agreement have not been disclosed.

The product is based on the Gibson Assembly method.

Gibson Assembly uses a one-step, isothermal approach to enable the rapid assembly of multiple DNA fragments.

The Gibson Assembly Master Mix includes protocols for primer design, and can be used for assembly of multiple DNA fragments, including linearized vector and insert.

The product can be used by researchers to assemble such synthetic nucleic acids into larger genetic constructs.

SGI founder and CEO Craig Venter said the Gibson Assembly method is a powerful tool that will enable synthetic biology researchers to make rapid advances leading to new discoveries.